Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

56%

5 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4

3(37.5%)

N/A

2(25.0%)

Phase 3

2(25.0%)

Phase 1

1(12.5%)

8Total

Phase 4(3)

N/A(2)

Phase 3(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06223269Phase 3Recruiting

Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting

Role: collaborator

NCT06073301Phase 4Active Not Recruiting

AFS Compared to AHC in Treatment of Necrotizing Fasciitis NF

Role: collaborator

NCT03695939Phase 1Completed

Evaluation of Safety and Efficacy of realSKIN® (Skin Xenotransplant) for Complete Closure of Severe Burn Wounds

Role: collaborator

NCT05477225Phase 4Unknown

A Randomized, Controlled Trial Comparing the Use of a Biodegradable Temporizing Matrix to Cadaver Skin in the Reconstruction of Hidradenitis Suppurativa Excisions

Role: lead

NCT05499104Phase 3Completed

A Trial Comparing a Cellulose Dressing to Two Standard of Care Dressings in Treating Split Thickness Donor Sites in Burn and Wound Patients.

Role: lead

NCT04593693Not ApplicableCompleted

A Dual-center Study Evaluating Clinical Acceptance of a NPWT Wound Care System

Role: collaborator

NCT04252651Unknown

Association of Cytokines With the Development of Complications in Burn and Toxic Epidermal Necrolysis (TENS) Patients

Role: lead

NCT03941535Phase 4Unknown

Comparison of Vitamin K Doses in Patients With Larger Burn Injuries

Role: lead

NCT03670225Not ApplicableCompleted

Evaluating Clinical Acceptance of a NPWT Wound Care System

Role: collaborator

All 9 trials loaded